Abbott and the Brain Injury Association of America have cofounded Concussion Awareness Now, a coalition of nearly 20 advocacy groups. They are teaming up with actress, comedian, writer, and producer Rebel Wilson to raise awareness of the seriousness of concussions....
A new study published in The Lancet Neurology demonstrates the ability of two blood-based biomarkers to predict how someone will recover from traumatic brain injury. A blood test for these two biomarkers in the immediate aftermath of an injury can help health care...
Abbott has launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality that will help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain. This upgrade is part...
Abbott announces the upcoming launch of NeuroSphere myPath, a digital health app designed to track and report on patient-perceived pain relief and general well-being associated with spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy. During the...
Abbott has received approval from the US Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple smartphone devices, it announces. This app approval gives patients living with neurological conditions,...
